IFP Advisors, Inc - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 71 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q1 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q2 2018$4,000
-20.0%
1500.0%0.00%
Q1 2018$5,0000.0%1500.0%0.00%
Q4 2017$5,0000.0%1500.0%0.00%
Q3 2017$5,000
+25.0%
1500.0%0.00%
Q2 2017$4,0000.0%1500.0%0.00%
Q1 2017$4,000
+33.3%
1500.0%0.00%
Q4 2016$3,000
-25.0%
1500.0%0.00%
Q3 2016$4,000
+100.0%
1500.0%0.00%
Q2 2016$2,000
-50.0%
1500.0%0.00%
Q4 2015$4,0001500.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q1 2016
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 3,440,419$110,713,00017.54%
Consonance Capital Management LP 2,079,311$66,912,0006.04%
RTW INVESTMENTS, LP 1,063,170$34,213,0005.71%
Broadfin Capital, LLC 1,029,866$33,141,0005.42%
Perceptive Advisors 3,388,611$109,046,0003.62%
SECTORAL ASSET MANAGEMENT INC 854,301$27,491,0003.44%
Boxer Capital, LLC 267,500$8,608,0001.57%
Ghost Tree Capital, LLC 200,000$6,436,0001.51%
EMORY UNIVERSITY 51,632$1,662,0001.43%
Stanley-Laman Group, Ltd. 168,653$5,427,0001.17%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders